Search results
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 1 day agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...
Study: Older Adults With Aggressive Blood Cancer A | Newswise
Newswise· 7 days agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...
North Crawford High School Band performs song for seven-year-old based on her book of surviving...
WKBT La Crosse· 15 hours agoNORTH CRAWFORD, (WKBT)-- Ruby Ihm was only three years old when she was diagnosed with cancer. For...
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA)...
WTRF Wheeling· 8 hours agoMoleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
Patients Over 80 Still Benefit From Treatment for AML Blood Cancer
Alaska Superstation· 2 days agoSeniors over 80 with acute myeloid leukemia can safely and effectively take the standard targeted...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
CBS 47 Fresno· 2 days agoAs of May 9, 2024, Ryvu's cash position was $59.0M, inclusive of the first tranche of €8M in venture debt from the EIB, obtained in March. This cash position, and other secured funding sources ...
Q1 2024 Bio Path Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 17 hours agoTurning now to the progress we have made with our lead product candidate, prexigebersen. As you know, last year, we reported positive interim results from Stage 2 of our Phase 2 clinical trial ...
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for...
WRBL Columbus· 20 hours agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the ...
Cancer Survivors Are Sharing Their First Cancer Symptoms, And As A Hypochondriac, I Am Calling My...
BuzzFeed via Yahoo News· 8 hours ago"Moral of the story: GET IT CHECKED!!! If the doctor pooh-poohs it, get it checked by a different...
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript May 8, 2024 Syndax...
